Clinical Trial Update: Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating human umbilical cord-derived mesenchymal stromal cells for systemic sclerosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Human umbilical cord-derived mesenchymal stromal cells (mesenchymal stromal cells (human umbilical cord-derived))

Snippet

Sponsor: Marie Hudson, MD | Conditions: Sclerosis, Systemic, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: RECRUITING